Alaska
Prescription drug spending and prescribing in Alaska, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $396M for prescriptions written in Alaska, the 51st most of 52 states and territories, and 3.9% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $396M
- Medicaid drugs, 2025: $213M
- Opioid share of claims: 3.9%
- Life-science raises, 2 years: $3M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Alaska | United States | Difference |
|---|---|---|---|
| Opioids | 3.9% | 3.5% | +10% |
| Antibiotics | 3.9% | 4.4% | -11% |
| Antipsychotics | 2.6% | 1.7% | +48% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Alaska's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Thyroid,pork | 5.3× | 2,854 |
| Prazosin Hcl | 2.7× | 3,925 |
| Nebivolol Hcl | 2.3× | 3,721 |
| Dutasteride | 2.2× | 2,346 |
| Lidocaine | 2.1× | 4,144 |
| Olanzapine | 2.1× | 9,205 |
| Buprenorphine Hcl/Naloxone Hcl | 1.8× | 3,746 |
| Torsemide | 1.8× | 6,115 |
| Ipratropium/Albuterol Sulfate | 1.8× | 2,508 |
| Estradiol | 1.7× | 10,073 |
Biggest Medicaid Drugs
What Alaska's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
2 Form D raises by companies based in Alaska in the last two years; the 10 largest. See all raises- Surgery Center of Wasilla, LLC$2M · Other health care · Jun 26, 2026
- Surgery Center of Wasilla, LLC$406K · Other health care · Jun 26, 2026
State Attorney General Health-Care Cases
Antitrust cases Alaska joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- FTC and Plaintiff States v. Mallilnckrodt Ard Inc. (formerly Questcor), No. 1:17-cv-00120 (D.D.C. Jan. 18, 2017)2017 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
- In re Cardizem CD Antitrust Litigation 99-MD-1278 (E.D. Mich. Jan. 29, 2003), 332 F.3d 896 (6th Cir. 2003)2003 · Settled
Other States
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG